1
|
Verlaat L, Rijks N, Dilai J, Admiraal M, Beudel M, de Bie RM, van der Zwaag W, Schuurman R, van den Munckhof P, Bot M. 7-Tesla Magnetic Resonance Imaging Scanning in Deep Brain Stimulation for Parkinson's Disease: Improving Visualization of the Dorsolateral Subthalamic Nucleus. Mov Disord Clin Pract 2024; 11:373-380. [PMID: 38385792 PMCID: PMC10982587 DOI: 10.1002/mdc3.13982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 12/14/2023] [Accepted: 01/05/2024] [Indexed: 02/23/2024] Open
Abstract
BACKGROUND Identifying the dorsolateral subthalamic nucleus (STN) for deep brain stimulation (DBS) in Parkinson's disease (PD) can be challenging due to the size and double-oblique orientation. Since 2015 we implemented 7-Tesla T2 weighted magnetic resonance imaging (7 T T2) for improving visualization and targeting of the dorsolateral STN. We describe the changes in surgical planning and outcome since implementation of 7 T T2 for DBS in PD. METHODS By comparing two cohorts of STN DBS patients in different time periods we evaluated the influence of 7 T T2 on STN target planning, the number of microelectrode recording (MER) trajectories, length of STN activity and the postoperative motor (UPDRS) improvement. RESULTS From February 2007 to January 2014, 1.5 and 3-Tesla T2 guided STN DBS with 3 MER channels was performed in 76 PD patients. Average length of recorded STN activity in the definite electrode trajectory was 3.9 ± 1.5 mm. From January 2015 to January 2022 7 T T2 and MER-guided STN DBS was performed in 182 PD patients. Average length of recorded STN activity in the definite electrode trajectory was 5.1 ± 1.3 mm and used MER channels decreased from 3 to 1. Average UPDRS improvement was comparable. CONCLUSION Implementation of 7 T T2 for STN DBS enabled a refinement in targeting. Combining classical DBS targeting with dorsolateral STN alignment may be used to determine the optimal trajectory. The improvement in dorsolateral STN visualization can be used for further target refinements, for example adding probabilistic subthalamic connectivity, to enhance clinical outcome of STN DBS.
Collapse
Affiliation(s)
- Lisa Verlaat
- Department of NeurosurgeryUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Niels Rijks
- Department of NeurosurgeryUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - José Dilai
- Department of Neurology and Clinical NeurophysiologyUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Marjolein Admiraal
- Department of Neurology and Clinical NeurophysiologyUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Martijn Beudel
- Department of Neurology and Clinical NeurophysiologyUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Rob M.A. de Bie
- Department of Neurology and Clinical NeurophysiologyUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Wietske van der Zwaag
- Spinoza Centre for Neuroimaging, Royal Netherlands Academy of Arts and SciencesAmsterdamthe Netherlands
| | - Rick Schuurman
- Department of NeurosurgeryUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Pepijn van den Munckhof
- Department of NeurosurgeryUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| | - Maarten Bot
- Department of NeurosurgeryUniversity Medical Centers, Academic Medical CenterAmsterdamthe Netherlands
| |
Collapse
|
2
|
Swinnen BE, de Bie RM, Hallett M, Helmich RC, Buijink AW. Reconstructing Re-emergent Tremor. Mov Disord Clin Pract 2023; 10:1293-1296. [PMID: 37772284 PMCID: PMC10525057 DOI: 10.1002/mdc3.13806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 05/25/2023] [Accepted: 05/26/2023] [Indexed: 09/30/2023] Open
Affiliation(s)
- Bart E.K.S. Swinnen
- Department of Neurology and Clinical NeurophysiologyAmsterdam University Medical Centers, Amsterdam Neuroscience, University of AmsterdamAmsterdamThe Netherlands
| | - Rob M.A. de Bie
- Department of Neurology and Clinical NeurophysiologyAmsterdam University Medical Centers, Amsterdam Neuroscience, University of AmsterdamAmsterdamThe Netherlands
| | - Mark Hallett
- Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of HealthBethesdaMarylandUSA
| | - Rick C. Helmich
- Department of Neurology, Centre of Expertise for Parkinson and Movement DisordersRadboud University Medical CentreNijmegenThe Netherlands
- Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and BehaviourRadboud UniversityNijmegenThe Netherlands
| | - Arthur W.G. Buijink
- Department of Neurology and Clinical NeurophysiologyAmsterdam University Medical Centers, Amsterdam Neuroscience, University of AmsterdamAmsterdamThe Netherlands
| |
Collapse
|
3
|
Pal G, Mangone G, Ouyang B, Ehrlich D, Saunders-Pullman R, Bressman S, Alcalay RN, Marder K, Aasly J, Mouradian M, Anderson S, Bernard B, Stebbins G, Sani S, Afshari M, Verhagen L, de Bie RM, Foltynie T, Hall D, Corvol JC, Goetz CG. Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease. Ann Neurol 2022; 92:345-346. [PMID: 35687082 PMCID: PMC10540153 DOI: 10.1002/ana.26433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Accepted: 06/08/2022] [Indexed: 11/11/2022]
Affiliation(s)
- Gian Pal
- Department of Neurology, Rutgers-Robert Wood Johnson
Medical School, New Brunswick, NJ, USA
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Graziella Mangone
- Sorbonne Université, Assistance Publique
Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau – Paris Brain
Institute – ICM, Pitié-Salpêtrière Hospital, Department
of Neurology, Centre d’Investigation Clinique Neurosciences, Paris,
France
| | - Bichun Ouyang
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Debra Ehrlich
- Parkinson’s Disease Clinic, Office of the Clinical
Director, NIH/NINDS, Bethesda, MD, USA
| | - Rachel Saunders-Pullman
- Department of Neurology, Mount Sinai Beth Israel, Icahn
School of Medicine at Mount Sinai, New York, New York, USA
| | - Susan Bressman
- Department of Neurology, Mount Sinai Beth Israel, Icahn
School of Medicine at Mount Sinai, New York, New York, USA
| | - Roy N. Alcalay
- Department of Neurology, College of Physicians and
Surgeons, Columbia University Medical Center, New York, NY, USA
| | - Karen Marder
- Department of Neurology, College of Physicians and
Surgeons, Columbia University Medical Center, New York, NY, USA
| | - Jan Aasly
- Department of Neurology, St. Olavs Hospital and Department
of Neuroscience, Norwegian University of Science and Technology, Trondheim, 7030,
Norway
| | - Maral Mouradian
- Department of Neurology, Rutgers-Robert Wood Johnson
Medical School, New Brunswick, NJ, USA
- Robert Wood Johnson Medical School Institute for
Neurological Therapeutics, Rutgers Biomedical and Health Sciences, Piscataway, NJ,
USA
| | - Sharlet Anderson
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Bryan Bernard
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Glenn Stebbins
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Sepehr Sani
- Department of Neurosurgery, Rush University Medical Center,
Chicago, IL, USA
| | - Mitra Afshari
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Leo Verhagen
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Rob M.A. de Bie
- Amsterdam University Medical Centers, University of
Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam,
Netherlands
| | - Tom Foltynie
- Department of Clinical & Movement Neurosciences, UCL
Institute of Neurology, London, UK
| | - Deborah Hall
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| | - Jean-Christophe Corvol
- Sorbonne Université, Assistance Publique
Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau – Paris Brain
Institute – ICM, Pitié-Salpêtrière Hospital, Department
of Neurology, Centre d’Investigation Clinique Neurosciences, Paris,
France
| | - Christopher G. Goetz
- Department of Neurological Sciences, Rush University
Medical Center, Chicago, IL, USA
| |
Collapse
|
4
|
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RM, Foltynie T, Hall D, Corvol JC, Goetz CG. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol 2022; 91:424-435. [PMID: 34984729 PMCID: PMC8857042 DOI: 10.1002/ana.26302] [Citation(s) in RCA: 39] [Impact Index Per Article: 19.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 01/01/2022] [Accepted: 01/03/2022] [Indexed: 12/16/2022]
Abstract
OBJECTIVE This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. METHODS Clinical and genetic data from 12 datasets were examined. Global cognition was assessed using the Mattis Dementia Rating Scale (MDRS). Subjects were examined for mutations in GBA and categorized as GBA carriers with or without DBS (GBA+DBS+, GBA+DBS-), and noncarriers with or without DBS (GBA-DBS+, GBA-DBS-). GBA mutation carriers were subcategorized according to mutation severity (risk variant, mild, severe). Linear mixed modeling was used to compare rate of change in MDRS scores over time among the groups according to GBA and DBS status and then according to GBA severity and DBS status. RESULTS Data were available for 366 subjects (58 GBA+DBS+, 82 GBA+DBS-, 98 GBA-DBS+, and 128 GBA-DBS- subjects), who were longitudinally followed (range = 36-60 months after surgery). Using the MDRS, GBA+DBS+ subjects declined on average 2.02 points/yr more than GBA-DBS- subjects (95% confidence interval [CI] = -2.35 to -1.69), 1.71 points/yr more than GBA+DBS- subjects (95% CI = -2.14 to -1.28), and 1.49 points/yr more than GBA-DBS+ subjects (95% CI = -1.80 to -1.18). INTERPRETATION Although not randomized, this composite analysis suggests that the combined effects of GBA mutations and STN-DBS negatively impact cognition. We advise that DBS candidates be screened for GBA mutations as part of the presurgical decision-making process. We advise that GBA mutation carriers be counseled regarding potential risks associated with STN-DBS so that alternative options may be considered. ANN NEUROL 2022;91:424-435.
Collapse
Affiliation(s)
- Gian Pal
- Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Graziella Mangone
- Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau – Paris Brain Institute – ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d’Investigation Clinique Neurosciences, Paris, France
| | - Emily J. Hill
- Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA
| | - Bichun Ouyang
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Yuanqing Liu
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Vanessa Lythe
- Department of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK
| | - Debra Ehrlich
- Parkinson’s Disease Clinic, Office of the Clinical Director, NIH/NINDS, Bethesda, MD, USA
| | - Rachel Saunders-Pullman
- Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Vicki Shanker
- Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Susan Bressman
- Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Roy N. Alcalay
- Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
| | - Priscilla Garcia
- Department of Neurology, New York Medical College, Valhalla, NY, USA
| | - Karen S. Marder
- Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
| | - Jan Aasly
- Department of Neurology, St. Olavs Hospital and Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, 7030, Norway
| | - M. Maral Mouradian
- Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA
- Robert Wood Johnson Medical School Institute for Neurological Therapeutics, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA
| | - Samantha Link
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Marc Rosenbaum
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Sharlet Anderson
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Bryan Bernard
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Robert Wilson
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Glenn Stebbins
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - William C. Nichols
- Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
| | - Marie-Laure Welter
- Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau – Paris Brain Institute – ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d’Investigation Clinique Neurosciences, Paris, France
- Normandie Univ, CHU Rouen, Department of Neurophysiology, Rouen, France
| | - Sepehr Sani
- Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA
| | - Mitra Afshari
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Leo Verhagen
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Rob M.A. de Bie
- Amsterdam University Medical Centers, University of Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam, Netherlands
| | - Tom Foltynie
- Department of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK
| | - Deborah Hall
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Jean-Christophe Corvol
- Sorbonne Université, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Institut du Cerveau – Paris Brain Institute – ICM, Pitié-Salpêtrière Hospital, Department of Neurology, Centre d’Investigation Clinique Neurosciences, Paris, France
| | - Christopher G. Goetz
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
5
|
Verschuur CV, Suwijn SR, de Haan RJ, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts A, Dijkgraaf MG, de Bie RM. Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease. J Parkinsons Dis 2022; 12:2171-2178. [PMID: 35938258 PMCID: PMC9661337 DOI: 10.3233/jpd-223247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Accepted: 07/16/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND In the Levodopa in EArly Parkinson's disease (LEAP) study, 445 patients were randomized to levodopa/carbidopa 100/25 mg three times per day for 80 weeks (early-start) or placebo for 40 weeks followed by levodopa/carbidopa 100/25 mg three times per day for 40 weeks (delayed-start). OBJECTIVE This paper reports the results of the economic evaluation performed alongside the LEAP-study. METHODS Early-start treatment was evaluated versus delayed-start treatment, in which the cost-effectiveness analysis (CEA) and the cost-utility analysis (CUA) were performed from the societal perspective, including health care costs among providers, non-reimbursable out-of-pocket expenses of patients, employer costs of sick leave, and lowered productivity while at work. The outcome measure for the CEA was the extra cost per unit decrease on the Unified Parkinson's Disease Rating Scale 80 weeks after baseline. The outcome measure for the CUA was the extra costs per additional quality adjusted life year (QALY) during follow-up. RESULTS 212 patients in the early-start and 219 patients in the delayed-start group reported use of health care resources. With savings of € 59 per patient (BCa 95% CI: -829, 788) in the early-start compared to the delayed-start group, societal costs were balanced. The early-start group showed a mean of 1.30 QALYs (BCa 95% CI: 1.26, 1.33) versus 1.30 QALYs (BCa 95% CI: 1.27, 1.33) for the delayed-start group. Because of this negligible difference, incremental cost-effectiveness and cost-utility ratios were not calculated. CONCLUSION From an economic point of view, this study suggests that early treatment with levodopa is not more expensive than delayed treatment with levodopa.
Collapse
Affiliation(s)
- Constant V.M. Verschuur
- Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Sven R. Suwijn
- Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Rob J. de Haan
- Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Judith A. Boel
- Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Bart Post
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Bas R. Bloem
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands
| | | | - Teus van Laar
- Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands
| | - Gerrit Tissingh
- Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands
| | - Alexander Munts
- Department of Neurology, Excellent Klinieken, Dordrecht, The Netherlands
| | - Marcel G.W. Dijkgraaf
- Department of Epidemiology and Data Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| | - Rob M.A. de Bie
- Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
| |
Collapse
|
6
|
Zoon TJ, van Rooijen G, Balm GM, Bergfeld IO, Daams JG, Krack P, Denys DA, de Bie RM. Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis. Mov Disord 2021; 36:317-326. [PMID: 33331023 PMCID: PMC7986158 DOI: 10.1002/mds.28390] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 10/15/2020] [Accepted: 10/26/2020] [Indexed: 12/12/2022] Open
Abstract
Apathy, the loss of motivation, is a common problem in Parkinson's disease (PD) and often observed following deep brain stimulation (DBS) of the subthalamic nucleus (STN). The aim of this meta-analysis was to determine the occurrence of apathy following STN DBS in literature. Relevant articles were searched in PubMed/Medline, SCOPUS, EMBASE, and Web of Sciences electronic databases. Studies were included if they reported apathy scores pre- and post-DBS or the cross-sectional difference between PD patients receiving STN DBS and patients receiving medication only. Thirty-three articles were included in the meta-analyses from 6,658 screened articles by two authors independently. A total of 1,286 patients were included with a mean age (±standard deviation [SD]) of 58.4 ± 8.5 years and a disease duration of 11.0 ± 5.8 years. The apathy score measured by means of the Apathy Evaluation Scale (AES), Starkstein Apathy Scale (SAS), and the Lille Apathy Rating Scale (LARS) was significantly higher after DBS than pre-operatively (g = 0.34, 95% confidence interval [CI] = 0.19-0.48, P < 0.001). An equal, significant difference in severity of apathy was found between STN DBS and medication only (g = 0.36, 95% CI = 0.03-0.65; P = 0.004). Statistical heterogeneity was moderately high, but the effects stood strong after multiple analyses and were independent of tapering off dopaminergic medication. The findings of this meta-analysis indicate that apathy is increased after STN DBS compared to the pre-operative state and to medication only (systematic review registration number: PROSPERO CRD42019133932). © 2020 Universiteit van Amsterdam. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Thomas J.C. Zoon
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| | - Geeske van Rooijen
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| | - Georgina M.F.C. Balm
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| | - Isidoor O. Bergfeld
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
- Amsterdam Brain and CognitionAmsterdamthe Netherlands
| | - Joost G. Daams
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| | - Paul Krack
- Division of Movement Disorder, Department of NeurologyInselspital, University Hospital BernBernSwitzerland
| | - Damiaan A.J.P. Denys
- Department of Psychiatry, Amsterdam NeuroscienceAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| | - Rob M.A. de Bie
- Department of NeurologyAmsterdam University Medical Centers, University of AmsterdamAmsterdamthe Netherlands
| |
Collapse
|
7
|
den Heijer JM, Cullen VC, Quadri M, Schmitz A, Hilt DC, Lansbury P, Berendse HW, van de Berg WD, de Bie RM, Boertien JM, Boon AJ, Contarino MF, van Hilten JJ, Hoff JI, van Mierlo T, Munts AG, van der Plas AA, Ponsen MM, Baas F, Majoor‐Krakauer D, Bonifati V, van Laar T, Groeneveld GJ. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands. Mov Disord 2020; 35:1667-1674. [PMID: 32618053 PMCID: PMC7540512 DOI: 10.1002/mds.28112] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Revised: 04/17/2020] [Accepted: 05/01/2020] [Indexed: 12/31/2022] Open
Abstract
BACKGROUND The most common genetic risk factor for Parkinson's disease known is a damaging variant in the GBA1 gene. The entire GBA1 gene has rarely been studied in a large cohort from a single population. The objective of this study was to assess the entire GBA1 gene in Parkinson's disease from a single large population. METHODS The GBA1 gene was assessed in 3402 Dutch Parkinson's disease patients using next-generation sequencing. Frequencies were compared with Dutch controls (n = 655). Family history of Parkinson's disease was compared in carriers and noncarriers. RESULTS Fifteen percent of patients had a GBA1 nonsynonymous variant (including missense, frameshift, and recombinant alleles), compared with 6.4% of controls (OR, 2.6; P < 0.001). Eighteen novel variants were detected. Variants previously associated with Gaucher's disease were identified in 5.0% of patients compared with 1.5% of controls (OR, 3.4; P < 0.001). The rarely reported complex allele p.D140H + p.E326K appears to likely be a Dutch founder variant, found in 2.4% of patients and 0.9% of controls (OR, 2.7; P = 0.012). The number of first-degree relatives (excluding children) with Parkinson's disease was higher in p.D140H + p.E326K carriers (5.6%, 21 of 376) compared with p.E326K carriers (2.9%, 29 of 1014); OR, 2.0; P = 0.022, suggestive of a dose effect for different GBA1 variants. CONCLUSIONS Dutch Parkinson's disease patients display one of the largest frequencies of GBA1 variants reported so far, consisting in large part of the mild p.E326K variant and the more severe Dutch p.D140H + p.E326K founder allele. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Jonas M. den Heijer
- Centre for Human Drug ResearchLeidenThe Netherlands
- Leiden University Medical CenterLeidenThe Netherlands
| | | | - Marialuisa Quadri
- Erasmus Medical CenterRotterdamThe Netherlands
- Janssen Vaccines and PreventionLeidenThe Netherlands
| | | | - Dana C. Hilt
- Lysosomal Therapeutics IncCambridgeMassachusettsUSA
| | | | | | | | - Rob M.A. de Bie
- Amsterdam University Medical CentersAmsterdamThe Netherlands
| | | | | | - M. Fiorella Contarino
- Leiden University Medical CenterLeidenThe Netherlands
- Haga Teaching HospitalThe HagueThe Netherlands
| | | | | | | | | | | | | | - Frank Baas
- Leiden University Medical CenterLeidenThe Netherlands
| | | | | | - Teus van Laar
- University Medical Center GroningenGroningenThe Netherlands
| | - Geert J. Groeneveld
- Centre for Human Drug ResearchLeidenThe Netherlands
- Leiden University Medical CenterLeidenThe Netherlands
| |
Collapse
|
8
|
Overdijk MJ, de Bie RM, Berendse HW, van Rootselaar AF. An Unusual Dystonic Manifestation in Wilson's Disease. Mov Disord Clin Pract 2018; 5:546-547. [DOI: 10.1002/mdc3.12639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 04/29/2018] [Accepted: 05/07/2018] [Indexed: 11/09/2022] Open
Affiliation(s)
- M. Joleine Overdijk
- Department of Neurology/Clinical Neurophysiology; IJsselland Hospital; Capelle aan den IJssel Netherlands
- Department of Neurology/Clinical Neurophysiology; Academic Medical Center; Amsterdam Netherlands
| | - Rob M.A. de Bie
- Department of Neurology/Clinical Neurophysiology; Academic Medical Center; Amsterdam Netherlands
| | - Henk W. Berendse
- Department of Neurology; VU University Medical Center; Amsterdam Netherlands
| | | |
Collapse
|
9
|
Hoogland J, Boel JA, de Bie RM, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Mov Disord 2017; 32:1056-1065. [DOI: 10.1002/mds.27002] [Citation(s) in RCA: 89] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 03/09/2017] [Accepted: 03/10/2017] [Indexed: 01/14/2023] Open
Affiliation(s)
- Jeroen Hoogland
- Department of Neurology; Academic Medical Center Amsterdam; Amsterdam The Netherlands
| | - Judith A. Boel
- Department of Neurology; Academic Medical Center Amsterdam; Amsterdam The Netherlands
- Department of Psychology; University of Amsterdam; Amsterdam The Netherlands
| | - Rob M.A. de Bie
- Department of Neurology; Academic Medical Center Amsterdam; Amsterdam The Netherlands
| | - Ronald B. Geskus
- Department of Clinical Epidemiology; Biostatistics and Bioinformatics, Academic Medical Center Amsterdam; Amsterdam The Netherlands
| | - Ben A. Schmand
- Department of Psychology; University of Amsterdam; Amsterdam The Netherlands
- Department of Medical Psychology; Academic Medical Center Amsterdam; Amsterdam The Netherlands
| | - John C. Dalrymple-Alford
- New Zealand Brain Research Institute, Brain Research New Zealand, Centre of Research Excellence; Christchurch New Zealand
| | - Connie Marras
- Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital; University of Toronto; Toronto Ontario Canada
| | - Charles H. Adler
- Arizona Parkinson's Disease Consortium, Mayo Clinic Arizona, Scottsdale, Arizona, USA, and Banner Sun Health Research Institute; Sun City Arizona USA
| | - Jennifer G. Goldman
- Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders; Rush University Medical Center; Chicago Illinois USA
| | - Alexander I. Tröster
- Department of Clinical Neuropsychology and Center for Neuromodulation; Barrow Neurological Institute; Phoenix Arizona USA
| | - David J. Burn
- Institute of Neuroscience; Newcastle University; Newcastle upon Tyne United Kingdom
| | - Irene Litvan
- Department of Neurosciences University of California San Diego; Movement Disorder Center; San Diego California USA
| | - Gert J. Geurtsen
- Department of Medical Psychology; Academic Medical Center Amsterdam; Amsterdam The Netherlands
| | | |
Collapse
|
10
|
Boel JA, Odekerken VJ, Schmand BA, Geurtsen GJ, Cath DC, Figee M, van den Munckhof P, de Haan RJ, Schuurman PR, de Bie RM, Odekerken VJ, Boel JA, van Laar T, van Dijk J, Mosch A, Hoffmann CF, Nijssen PC, van Asseldonk T, Beute GN, van Vugt JP, Lenders MW, Fiorella Contarino M, Bour LJ, Geurtsen GJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 2016; 33:90-95. [DOI: 10.1016/j.parkreldis.2016.09.018] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Revised: 09/12/2016] [Accepted: 09/18/2016] [Indexed: 10/21/2022]
|
11
|
Verhagen R, Schuurman P, van den Munckhof P, Contarino M, de Bie RM, Bour LJ. Comparative study of microrecording-based STN location and MRI-based STN location. Parkinsonism Relat Disord 2016. [DOI: 10.1016/j.parkreldis.2015.10.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
den Brok MG, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RM, Richard E. Apathy in Parkinson's disease: A systematic review and meta-analysis. Mov Disord 2015; 30:759-69. [DOI: 10.1002/mds.26208] [Citation(s) in RCA: 220] [Impact Index Per Article: 24.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2014] [Revised: 02/05/2015] [Accepted: 02/12/2015] [Indexed: 01/24/2023] Open
Affiliation(s)
| | | | - Willem A. van Gool
- Department of Neurology; Academic Medical Center Amsterdam; The Netherlands
| | | | - Rob M.A. de Bie
- Department of Neurology; Academic Medical Center Amsterdam; The Netherlands
| | - Edo Richard
- Department of Neurology; Radboud University Medical Center Nijmegen; The Netherlands
- Department of Neurology; Academic Medical Center Amsterdam; The Netherlands
| |
Collapse
|
13
|
Contarino MF, Speelman JD, de Bie RM, Schuurman PR, van den Munckhof P. Bilateral cerebellorubrothalamic fibers stimulation for essential tremor? Mov Disord 2011; 26:1366-7. [DOI: 10.1002/mds.23542] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2010] [Revised: 10/14/2010] [Accepted: 10/18/2010] [Indexed: 11/06/2022] Open
|
14
|
Hoogland J, de Bie RM, Williams-Gray CH, Muslimović D, Schmand B, Post B. Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease. Mov Disord 2010; 25:2550-4. [DOI: 10.1002/mds.23319] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
15
|
Groen JL, Ritz K, Contarino MF, van de Warrenburg BP, Aramideh M, Foncke EM, van Hilten JJ, Schuurman PR, Speelman JD, Koelman JH, de Bie RM, Baas F, Tijssen MA. DYT6 dystonia: Mutation screening, phenotype, and response to deep brain stimulation. Mov Disord 2010; 25:2420-7. [DOI: 10.1002/mds.23285] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
16
|
Surie S, Tijssen MA, Biervliet JD, de Beaumont EM, Kloek JJ, Rutten PM, Smeding HM, Bresser P, de Bie RM. Chorea in adults following pulmonary endarterectomy. Mov Disord 2010; 25:1101-4. [DOI: 10.1002/mds.23044] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Vis JC, Timmermans J, Post MC, Budts W, Schepens MA, Thijs V, Schonewille WJ, de Bie RM, Plokker HW, Tijssen JG, Mulder BJ. Increased prevalence of migraine in Marfan syndrome. Int J Cardiol 2009; 136:330-4. [DOI: 10.1016/j.ijcard.2008.05.037] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/29/2008] [Revised: 05/08/2008] [Accepted: 05/18/2008] [Indexed: 11/16/2022]
|